DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Hess G, Herbrecht R, Romaguera J. et al.
Phase III study to evaluate temsirolimus compared with investigator’s choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.
J Clin Oncol 2009;
27: 3822-3829
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.